share_log

Barclays Downgrades Helmerich & Payne to Equal-Weight, Lowers Price Target to $40

Barclays Downgrades Helmerich & Payne to Equal-Weight, Lowers Price Target to $40

巴克萊將Helmerich和Payne的評級下調至同等權重,將目標股價下調至40美元
Benzinga ·  01/10 06:48

Barclays analyst David Anderson downgrades Helmerich & Payne (NYSE:HP) from Overweight to Equal-Weight and lowers the price target from $44 to $40.

巴克萊分析師戴維·安德森將Helmerich & Payne(紐約證券交易所代碼:HP)的評級從增持下調至同等,並將目標股價從44美元下調至40美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論